ML22059B011

Letter to the Honorable Frank Pallone, Jr. from Eugene Dacus, OCA, Providing Copy of the 2022 FACA Charter

ML22059B011
Person / Time
Issue date:	02/28/2022
From:	Eugene Dacus Office of Congressional Affairs, NRC/SECY
To:
Russell Chazell
References
Download: ML22059B011 (3)

Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001

February 28, 2022

The Honorable Frank P allone, Jr.

Chairman, Committee on Energy and Commerce United States House of Representatives Washington, D.C. 20515

Dear Mr. Chairman:

In accordance with the requirements of the Federal Advisory Committee Act, the U.S.

Nuclear Regulatory Commission (NRC) is filing the charter for the Advisory Committee on the

Medical Uses of Isotopes (ACMUI). The ACMUI provides advice on policy and technical issues

that arise in regulating medical use of byproduct material for diagnosis and therapy. The

enclosed charter for this Committee updates the document previously filed by the NRC in

February 2020 and extends the life of the Committee through February 2024.

Sincerely,

Eugene Dacus, Director Office of Congressional Affairs

Enclosure:

As stated

cc: Representative Cathy McMorris Rodgers UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES

1. Committee's Official Designation (Title):

Advisory Committee on the Medical Uses of Isotopes (the Committee or ACMUI)

2. Authority:

The Committee is established pursuant to 42 United States Code§ 2201 (a) as an NRC discretionary committee in a c cordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App.

3. Objectives and Scope of Activities:

The Committee provides advice, as requested by the Director, Division of Materials Safety,

Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in the regulation of the medical uses of radioactive material for diagnosis and therapy.

4. Description of Duties:

The Committee comments on changes to relevant NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing, inspection, and enforcement cases ; and brings key issues to the attention of the agency for appropriate action. The Committee members may also serve as medical consultants to the Director, MSST, as requested.

5. Official to Whom this Committee Reports:

Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington, DC 20555

6. Agency Responsible for Providing Necessary Support to this Committee:

U.S. Nuclear Regulatory Commission.

7. Estimated Annual Operating Costs and Staff Years:

As of the date of this charter, estimated annual operating costs for the full committee total

$308,000. These costs include 1.61 FTE (1.05 FTE for NRC support staff salary and benefits and 0.56 FTE for ACMUI member compensation) and travel reimbursements for NRC staff, ACMUI members, and consultants.

8. Designated Federal Officer:

A full-time NRC employee from the NRC 's Division of Materials Safety, Security, State, and Tribal Programs will serve a s the Designated Federal Officer (DFO). The DFO will approve or call all of the committee and subcommittee meetings, prepare and approve all meeting agendas, attend all committee and subcommittee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the Director, MSST.

9. Estimated Number of Meetings per Year:

Approximately six meetings per year, four of which are web conferences, with video and telephone capabilities.

10. Duration:

Continuing Committee.

11. Termination:

Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed.

12. Membership and Designation:

With the exception of one regular Government employee representing the U.S. Food and Drug Administration, members are appointed by the Director, NMSS as Special Government Employees. The Committee consists of 13 members, including health care professionals in diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy, and an Agreement State representative.

13. Subcommittees:

The Committee does not have standing subcommittees. The full Committee may create ad hoc subcommittees that report to the full Committee.

14. Recordkeeping:

The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C. 552.

15. Filing date:

February 28, 2022

Federal Advisory Committee Management Officer Office of the Secretary